— Know what they know.
Not Investment Advice

RUA.NZ NZE

Rua Bioscience Limited
1W: -3.6% 1M: -22.9% 3M: -6.9% YTD: -15.6% 1Y: -53.5% 3Y: -74.3% 5Y: -92.4%
NZ$0.03 ($0.02)
+0.00 (+3.70%)
 
Weekly Expected Move ±11.1%
NZ$0 NZ$0 NZ$0 NZ$0 NZ$0
NZE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 34 · NZ$7.2M mcap · 162M float · 0.049% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapNZ$7.2M ($4.0M)
52W Range0.026-0.043
Volume17,964
Avg Volume79,356
Beta0.52
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOPaul Naske
Employees15
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2020-10-21
Websiteruabio.com
704 Te Araroa Road
Ruatoria, GI 4083
NZ
64 800 782 246
About Rua Bioscience Limited

Rua Bioscience Limited, a company founded in 2016 and headquartered in Gisborne, New Zealand, is dedicated to the investigation, refinement, and production of medicinal products for both the New Zealand market and international distribution. Their offerings primarily include pharmaceuticals developed from cannabinoids. The firm officially changed its name to Rua Bioscience Limited in October 2019, having previously been known as Hikurangi Cannabis Company Limited.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms